Eyeing Multiple Development Paths, Pronutria Takes $12.5 Million Series B
This article was originally published in The Pink Sheet Daily
Executive Summary
The Cambridge, Mass.-based developer of medical foods and supplements has begun clinical trials on two candidates to stave off muscle loss in elderly people. It soon may begin development of therapeutic product candidates within a separate business unit.